Babesia duncani (WA1) Antibody IgG IFA Biomarker Testing
It measures IgG antibodies to Babesia duncani (WA1) to support exposure assessment and follow-up, with easy ordering through Vitals Vault/Quest.
With Vitals Vault, you have access to a comprehensive range of biomarker tests.
This test looks for IgG antibodies to Babesia duncani (also called WA1), a parasite that can infect red blood cells and cause babesiosis.
An antibody result does not directly “count parasites.” Instead, it shows whether your immune system has reacted to Babesia duncani at some point, which can help your clinician decide what follow-up testing makes sense.
Because symptoms can overlap with many other conditions, the most useful way to read this result is alongside your timeline (when symptoms started, possible tick exposure, prior treatment) and any direct-detection tests your clinician orders.
Do I need a Babesia duncani (WA1) Antibody IgG IFA test?
You may consider Babesia duncani (WA1) IgG IFA testing if you have ongoing, unexplained symptoms after possible tick exposure, especially when symptoms come in waves. People often describe fatigue that feels out of proportion, drenching sweats or chills, shortness of breath with exertion, headaches, or a “flu-like” pattern that keeps returning.
Testing can also be reasonable if you have anemia or low platelets on routine bloodwork without a clear cause, or if you are being evaluated for a broader tick-borne illness picture and your clinician wants to include Babesia in the differential.
If you are currently very ill, immunocompromised, pregnant, or you have signs of significant anemia (such as chest pain, fainting, or severe shortness of breath), antibody testing alone is usually not enough. In those situations, clinicians often prioritize direct detection (such as a blood smear or PCR) because it can identify active infection sooner.
This test supports clinician-directed care and follow-up planning, but it cannot diagnose or rule out babesiosis by itself.
This is a CLIA-performed indirect fluorescent antibody (IFA) serology test; results should be interpreted with symptoms, exposure history, and confirmatory testing when needed.
Lab testing
Order Babesia duncani (WA1) IgG IFA through Vitals Vault and complete your blood draw at a participating lab location.
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this test with Vitals Vault
Vitals Vault lets you order Babesia duncani (WA1) Antibody IgG IFA testing without needing to coordinate a separate lab requisition visit. You choose the test, complete checkout, and then visit a participating draw site for your blood sample.
When your result posts, you can use PocketMD to turn the lab language into next steps you can discuss with your clinician. That is especially helpful with tick-borne testing, where timing, prior antibiotics, and cross-reactivity can change what a single result means.
If your situation calls for it, you can also use Vitals Vault to add companion tests or repeat the same test later to look for a changing pattern rather than relying on one snapshot.
- Order online and complete your blood draw at a participating lab location
- PocketMD helps you prepare questions for your clinician based on your result
- Easy re-ordering if your clinician recommends follow-up testing
Key benefits of Babesia duncani (WA1) IgG IFA testing
- Helps assess whether your immune system has reacted to Babesia duncani (WA1) exposure.
- Adds context when symptoms suggest a relapsing, tick-borne pattern but routine labs are non-specific.
- Supports a more targeted follow-up plan, such as pairing serology with PCR or blood smear when appropriate.
- Can help distinguish “never exposed” from “possible past exposure,” which changes how clinicians interpret current symptoms.
- Provides a baseline that can be compared with future titers if your clinician is tracking change over time.
- May help explain certain blood count abnormalities (like anemia or low platelets) when Babesia is on the differential.
- Pairs well with PocketMD guidance so you can discuss timing, limitations, and next steps with your clinician.
What is Babesia duncani (WA1) Antibody IgG IFA?
Babesia duncani is a protozoan parasite that can infect red blood cells. The immune system may respond by making antibodies, including IgG antibodies, after exposure.
This test uses an indirect fluorescent antibody (IFA) method to look for IgG antibodies that bind to Babesia duncani (WA1) antigens. Labs typically report the result as a titer (for example, 1:64, 1:256, etc.), which reflects how much the sample can be diluted while still showing antibody binding.
IgG antibodies usually develop after the earliest phase of infection. That means an IgG IFA can be helpful for assessing prior exposure or later-stage immune response, but it can miss very early infection. It also cannot reliably tell you whether organisms are currently present in your blood.
A positive antibody result can also persist after an infection has resolved, and some people—especially those with weakened immune systems—may not mount a strong antibody response even with active infection.
What do my Babesia duncani (WA1) Antibody IgG IFA results mean?
Low or negative Babesia duncani (WA1) IgG IFA
A low or negative result generally means the lab did not detect IgG antibodies at the reporting threshold. This can fit with no prior exposure, but it can also happen if you tested too early for IgG to develop. If your symptoms are recent (for example, within the last few weeks) or you are immunocompromised, your clinician may still consider PCR or a blood smear to look for active infection. If suspicion remains high, repeat serology in a few weeks may be discussed to look for seroconversion (a new rise from negative to positive).
In-range (non-reactive) result in context
For infectious serology, “optimal” usually means non-reactive at the lab’s cutoff rather than a health-optimization target. A non-reactive result can be reassuring when your exposure risk is low and your symptoms have another clear explanation. If your exposure risk is meaningful or symptoms strongly suggest babesiosis, your clinician may interpret a non-reactive IgG as incomplete information rather than a definitive rule-out. The right next step depends on timing, severity, and whether you have already taken antimicrobials.
High or positive Babesia duncani (WA1) IgG IFA
A high or positive IgG titer suggests your immune system has recognized Babesia duncani (WA1) at some point. It does not prove that you have an active infection today, because IgG can remain detectable after recovery. Clinicians often use the titer level, your symptom timeline, and whether the titer is rising on repeat testing to judge how concerning it is. If active infection is a concern—especially with anemia, fevers, or significant symptoms—confirmatory testing such as PCR and/or a blood smear may be recommended.
Factors that influence Babesia duncani (WA1) IgG IFA results
Timing matters: IgG may be negative early and become positive later, so the same person can have different results depending on when you test. Immune status matters too, because reduced antibody production can lead to falsely low results. Prior treatment can reduce detectable organisms without immediately changing antibody titers, which is why serology is not a reliable “test of cure.” Finally, cross-reactivity and lab-specific cutoffs can affect interpretation, so it helps to review the exact titer, reference range, and any companion Babesia tests ordered at the same time.
What’s included
- Babesia Duncani (Wa1) Antibody (Igg), Ifa
Frequently Asked Questions
What does a Babesia duncani (WA1) IgG IFA test detect?
It detects IgG antibodies your immune system may produce after exposure to Babesia duncani (WA1). It is an immune-response test, not a direct measurement of parasites in your blood.
Can this test diagnose active babesiosis?
Not by itself. A positive IgG supports possible exposure, but active infection is usually evaluated with your symptoms plus direct-detection tests such as PCR and/or a blood smear, especially when illness is acute or severe.
What is an IFA titer and how is it reported?
A titer is the highest dilution of your blood sample that still shows antibody binding under the IFA method. Labs report it as a ratio (for example, 1:64 or 1:256). Higher titers generally indicate more detectable antibody, but interpretation depends on the lab’s cutoff and your clinical context.
If my IgG is negative, does that rule out Babesia duncani?
No. Early infection can test negative before IgG develops, and some people do not mount strong antibody responses. If suspicion remains high, your clinician may recommend PCR, a blood smear, or repeat serology after a few weeks.
Should I fast before a Babesia duncani IgG IFA blood test?
Fasting is not typically required for antibody testing. If you are combining this with other labs (like lipids or glucose), follow the fasting instructions for those tests.
How soon after a tick bite should I test?
There is no single perfect window. IgG can take time to appear, so testing very soon after exposure may be negative even if infection develops. If you have acute symptoms, clinicians often use PCR and/or smear early, and consider repeating antibody testing later if needed.
Can IgG stay positive after treatment or recovery?
Yes. IgG antibodies can remain detectable for months or longer, which is why a positive IgG is not a reliable marker of cure. If your clinician is tracking response, they may rely more on symptoms and direct-detection tests when appropriate.